Skip Navigation

This Article
Right arrow Print PDF (3968K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (41)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by sun, L. Q.
Right arrow Articles by Symonds, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by sun, L. Q.
Right arrow Articles by Symonds, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1995, Vol. 23, No. 15 2909-2913
© 1995


RNA

Target sequence-specific inhibition of Hiv- replication by ribozymes directed to tatRNA

Lun Quan sun*, Li Wang, Wayne L. Gerlach and Geoff Symonds

The R.W. Johnson Pharmaceutical Research Institute Sydney, Johnson and Johnson Research Pty Limited GPO Box 3331, Sydney NSW 2001, Australia

*To Whom correspondence should be addressed

Received April 21, 1995. Accepted June 30, 1995.

The structural motif formed between a hammerhead ribozyme and its substrate consists of three RNA double helices In which the sequence 5' to the XUY is termed helix I and the sequence 3' to the XUY helix III. Two hammerhead ribozymes targeted to the tat gene of HIV-1 SF2 were designed to study target specificity and the potential effect of helix I mismatch on ribozyme efficacy both in vitro and in vivo. The first ribozyme (Rz1) targeted to the 5' splicing region of the tat gene was designed to cleave GUC*A. In HIV-11MB the A Is changed to a G. The second ribozyme (Rz2) was targeted to the translational Initiation region of the tat gene which is highly conserved among a variety of HIV-1 isolates, Including both HIV-1 SF2 and HIV-1 IIIB. In vitro cleavage studies demonstrated that Rz1 efficiently cleaved HIV-1 SF2 substrate RNA, but not HIV-1 IIIB, presumably due to the base change from A to G. In contrast, Rz2 cleaved HIV-1 SF2 or HIV-1 IIIB substrate with equal efficiency. Both ribozymes were cloned into the 3' untranslated region of the neomycin gene (neo) within the pSV2neo vector and transfected into the SupTl human CD4+ T cell line. Following selection, stable transfectants were challenged with either HIV-1 SF2 or HIV-1 IIIB virus. While Rz1-expressing cells were significantly protected from HIV-1 SF2 infection, they exhibited no protection when infected with HIV-1 IIIB virus. In contrast, Rz2 was effective in inhibiting the replication of both HIV-1 SF2 and HIV-1 IIIB In SupT1 cells. Expression of both ribozymes in these cells was demonstrated by Northern analysis. RT-PCR sequencing analysis confirmed the respective HIV-1 target sequence integrity. These data demonstrate the importance of the first base pair distal to the XUY within helix I of the hammerhead structure for both In vitro and in vivo ribozyme activities and imply that the effectiveness of the anti-HIV-1 ribozymes against appropriate target sequences is due to their catalytic activities rather than any antisense effect


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. A. Mir, T. J. Lockett, and P. Hendry
Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers
Nucleic Acids Res., May 1, 2001; 29(9): 1906 - 1914.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.